Candesartan reduced mortality and hospital admissions in chronic heart failure.

and commentary also appear in ACP Journal Club. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . For correspondence: Professor C H A R M-Overall: M A Pfeffer, Brigham and Women’s Hospital, Boston, MA, USA. [email protected] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . For correspondence: Professor C H A R M-Added: J McMurray, Western Infirmary, Glasgow, UK. [email protected] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . For correspondence: Dr C H A R M-Alternative: C B Granger, Duke University Medical Center, Durham, NC, USA. [email protected] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . For correspondence: Professor C H A R M-Preserved: S Yusuf, McMaster University, Hamilton, Ontario, Canada. [email protected] Source of funding: AstraZeneca R&D. 44 THERAPEUTICS www.evidence-basedmedicine.com group.bmj.com on June 18, 2017 Published by http://ebm.bmj.com/ Downloaded from